Treatment of intracranial gliomas with bone marrow-derived dendritic cells pulsed with tumor antigens

Journal of Neurosurgery

Volumn 90, Issue 6, 1999, Pages 1115-1124

  Liau, Linda M ^a   Black, Keith L ^a   Prins, Robert M ^a   Sykes, Steven N ^a   DiPatre, Pier Luigi ^a   Cloughesy, Timothy F ^a   Becker, Donald P ^a   Bronstein, Jeff M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antigen presenting cell; Brain neoplasm; Cytokine; Dendritic cell; Immunotherapy; Rat; Tumor vaccine

Indexed keywords

TUMOR ANTIGEN; TUMOR VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; BONE MARROW; CANCER IMMUNOTHERAPY; CANCER TRANSPLANTATION; CELL MEDIATED CYTOTOXICITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; GLIOMA; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; RAT; TUMOR IMMUNOLOGY;

EID: 0033007570     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/jns.1999.90.6.1115     Document Type: Article

References (41)

1. Armstrong CA, Botella R, Galloway TH, et al: Antitumor effects of granulocyte-macrophage colony-stimulating factor production by melanoma cells. Cancer Res 56:2191-2198, 1996
2. Ashley DM, Faiola B, Nair S, et al: Bone marrow-generated dendritic cells pulsed with tumor extracts or tumor RNA induce antitumor immunity against central nervous system tumors. J Exp Med 186:1177-1182, 1997
3. Bakker ABH, Marland G, de Boer AJ, et al: Generation of antimelanoma cytotoxic T lymphocytes from healthy donors after presentation of melanoma-associated antigen-derived epitopes by dendritic cells in vitro. Cancer Res 55:5330-5334, 1995
4. Bañuls MP, Alvarez A, Ferrero I, et al: Cell-surface marker analysis of rat thymic dendritic cells. Immunology 79: 298-304, 1993
5. Boczkowski D, Nair SK, Snyder D, et al: Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo. J Exp Med 184:465-472, 1996
6. Bouma GJ, van der Meer-Prins PM, van Bree FP, et al: Determination of cytotoxic T-lymphocyte precursor frequencies using europium labeling as a nonradioactive alternative to labeling with chromium-51. Hum Immunol 5:85-92, 1992
7. Brenan M, Puklavec M: The MRC OX62 antigen: a useful marker in the purification of rat veiled cells with the biochemical properties of an integrin. J Exp Med 175:1457-1465, 1992
8. Caux C, Dezutter-Dambuyant C, Schmitt D, et al: GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells. Nature 360:258-261, 1992
9. Chen-Woan M, Delaney CP, Fournier V, et al: In vitro characterization of rat bone marrow-derived dendritic cells and their precursors. J Leukoc Biol 59:196-207, 1996
10. Chen-Woan M, Delaney CP, Fournier V, et al: A new protocol for the propagation of dendritic cells from rat bone marrow using recombinant GM-CSF, and their quantification using the mAb OX-62. J Immunol Methods 178:157-171, 1995
11. + T cells. J Immunol 154:4915-4923, 1995
12. Couraud PO: Interactions between lymphocytes, macrophages, and central nervous system cells. J Leuko Biol 56:407-415, 1994
13. Davis FG, Freels S, Grutsch J, et al: Survival rates in patients with primary malignant brain tumors stratified by patient age and tumor histological type: an analysis based on surveillance, epidemiology, and end results (SEER) data, 1973-1991. J Neurosurg 88:1-10, 1998
14. Dranoff G, Jaffee E, Lazenby A, et al: Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc Natl Acad Sci USA 90:3539-3543, 1993
15. Fakhrai H, Dorigo O, Shawler DL, et al: Eradication of established intracranial rat gliomas by transforming growth factor β antisense gene therapy. Proc Natl Acad Sci USA 93: 2909-2914, 1996
16. Hsu FJ, Benike C, Fagnoni F, et al: Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nat Med 2:52-58, 1996
17. Inaba K, Inaba M, Romani N, et al: Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med 176:1693-1702, 1992
18. Kurpad SN, Wikstrand CJ, Bigner DD: Immunobiology of malignant astrocytomas. Semin Oncol 21:149-161, 1994
19. Leach DR, Krummel MF, Allison JP: Enhancement of antitumor immunity by CTLA-4 blockade. Science 271:1734-1736, 1996
20. + lymphocytes to peptide antigen in vivo. J Immunol 151:6742-6748, 1993
21. Lichtor T, Glick RP, Kim TS, et al: Prolonged survival of mice with glioma injected intracerebrally with double cytokine-secreting cells. J Neurosurg 83:1038-1044, 1995
22. Mayordomo JI, Zorina T, Storkus WJ, et al: Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity. Nat Med 1:1297-1302, 1995
23. Okada H, Tahara H, Shurin MR, et al: Bone marrow-derived dendritic cells pulsed with a tumor-specific peptide elicit effective anti-tumor immunity against intracranial neoplasms. Int J Cancer 78:196-201, 1998
24. Paglia P, Chiodoni C, Rodolfo M, et al: Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo. J Exp Med 183:317-322, 1996
25. Porgador A, Snyder D, Gilboa E: Induction of antitumor immunity using bone marrow-generated dendritic cells. J Immunol 156:2918-2926, 1996
26. Rapoport SL: Blood-Brain Barrier in Physiology and Medicine, New York: Raven Press, 1976
27. + progenitors in human bone marrow. J Immunol 149:2681-2688, 1992
28. Rubin JT, Lotze MT: Adoptive cellular immunotherapy of cancer, in Mitchell MS (ed): Biological Approaches to Cancer Treatment: Biomodulation. New York: McGraw-Hill, 1993, pp 379-410
29. Sallusto F, Lanzavecchia A: Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α. J Exp Med 179:1109-1118, 1994
30. + cell-mediated immunity against tumors located in the "immunologically privileged" central nervous system. Proc Natl Acad Sci USA 93:10399-10404, 1996
31. Schneider J, Hofman FM, Apuzzo MLJ, et al: Cytokines and immunoregulatory molecules in malignant glial neoplasms. J Neurosurg 77:265-273, 1992
32. Schuler G, Steinman RM: Dendritic cells as adjuvants for immune-mediated resistance to tumors. J Exp Med 186: 1183-1187, 1997
33. Song W, Kong HL, Carpenter H, et al: Dendritic cells genetically modified with an adenovirus vector encoding the cDNA for a model antigen induce protective and therapeutic antitumor immunity. J Exp Med 186:1247-1256, 1997
34. Steinman RM: The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 9:271-296, 1991
35. Storkus WJ, Zeh HJ III, Salter RD, et al: Identification of T-cell epitopes: rapid isolation of class I-presented peptides from viable cells by mild acid elution. J Immunother 14:94-103, 1993
36. Sudo Y, Shimazaki C, Ashihara E, et al: Synergistic effect of FLT-3 ligand on the granulocyte colony-stimulating factor-induced mobilization of hematopoietic stem cells and progenitor cells into blood in mice. Blood 89:3186-3191, 1997
37. + bone marrow precursors cultured with c-kit ligand, granulocyte-macrophage colony-stimulating factor, and TNF-α. J Immunol 154:5851-5861, 1995
38. Volgmann T, Klein-Struckmeier A, Mohr H: A fluorescence-based assay for quantitation of lymphokine-activated killer cell activity. J Immunol Methods 119:45-51, 1989
39. Young JW, Inaba K: Dendritic cells as adjuvants for class I major histocompatibility complex-restricted antitumor immunity. J Exp Med 183:7-11, 1996
40. Zitvogel L, Mayordomo JI, Tjandrawan T, et al: Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines. J Exp Med 183:87-97, 1996
41. Zorina T, Mayordomo J, Watkins S, et al: Culture of dendritic cells from murine bone marrow supplemented with GM-CSF and TNF-alpha. J Immunother 16:247, 1994 (Abstract)